Company Analysis Ekso Bionics Holdings, Inc.
1. Summary
Advantages
- The stock's return over the last year (1394.25%) is higher than the sector average (-2.93%).
Disadvantages
- Price (5.56 $) is higher than fair price (3.13 $)
- Dividends (0%) are below the sector average (0.5317%).
- Current debt level 22.45% has increased over 5 years from 18.93%.
- The company's current efficiency (ROE=-89.52%) is lower than the sector average (ROE=106.63%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Ekso Bionics Holdings, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -0.2% | -14.2% | 0.7% |
| 90 days | 7.3% | -4.1% | 2.3% |
| 1 year | 1394.3% | -2.9% | 20.4% |
EKSO vs Sector: Ekso Bionics Holdings, Inc. has outperformed the "Healthcare" sector by 1397.19% over the past year.
EKSO vs Market: Ekso Bionics Holdings, Inc. has outperformed the market by 1373.89% over the past year.
Stable price: EKSO is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: EKSO with weekly volatility of 26.81% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Above fair price: The current price (5.56 $) is higher than the fair price (3.13 $).
Price is higher than fair: The current price (5.56 $) is 43.7% higher than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (-5.59) is lower than that of the sector as a whole (33.49).
P/E vs Market: The company's P/E (-5.59) is higher than that of the market as a whole (-68.72).
5.3. P/BV
P/BV vs Sector: The company's P/BV (14.52) is lower than that of the sector as a whole (260.15).
P/BV vs Market: The company's P/BV (14.52) is lower than that of the market as a whole (51.39).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (10.29) is lower than that of the sector as a whole (129.83).
P/S vs Market: The company's P/S indicator (10.29) is lower than that of the market as a whole (148.63).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-19.46) is higher than that of the sector as a whole (-28.84).
EV/Ebitda vs Market: The company's EV/Ebitda (-19.46) is higher than that of the market as a whole (-95.22).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 6.98% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (6.98%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-598.11%).
6.4. ROE
ROE vs Sector: The company's ROE (-89.52%) is lower than that of the sector as a whole (106.63%).
ROE vs Market: The company's ROE (-89.52%) is lower than that of the market as a whole (-6.23%).
6.6. ROA
ROA vs Sector: The company's ROA (-40.78%) is lower than that of the sector as a whole (-2.32%).
ROA vs Market: The company's ROA (-40.78%) is lower than that of the market as a whole (38.59%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0.8343%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.66%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5317%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
